Period:
Draw Mode:
| Volume | 903,089 |
|
|||||
| News | - | ||||||
| Day High | 9.96 | Low High |
|||||
| Day Low | 9.63 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Maravai LifeSciences Holdings Inc | MRVI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.30 | -3.0% | 9.70 | 15:00:48 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 9.94 | 9.63 | 9.96 | 10.00 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 11,752 | 903,089 | $ 9.80 | $ 8,850,887 | - | 9.09 - 25.83 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:00:51 | 10 | $ 9.695 | USD |
Maravai LifeSciences Holdings Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.43B | 251.02M | - | 890.8M | 220.21M | 0.88 | 11.02 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Maravai LifeSciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRVI Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 9.60 | 10.25 | 9.09 | 9.49 | 2,105,327 | 0.10 | 1.04% |
| 1 Month | 10.27 | 11.26 | 9.09 | 10.18 | 2,228,794 | -0.57 | -5.55% |
| 3 Months | 12.12 | 13.31 | 9.09 | 10.91 | 2,481,882 | -2.42 | -19.97% |
| 6 Months | 13.96 | 16.62 | 9.09 | 12.22 | 2,567,502 | -4.26 | -30.52% |
| 1 Year | 25.60 | 25.83 | 9.09 | 13.57 | 2,176,908 | -15.90 | -62.11% |
| 3 Years | 31.11 | 63.55 | 9.09 | 26.08 | 1,773,598 | -21.41 | -68.82% |
| 5 Years | 31.11 | 63.55 | 9.09 | 26.08 | 1,773,598 | -21.41 | -68.82% |
Maravai LifeSciences Description
| Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It generates a majority of its revenue from the Nucleic Acid Production that focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples. |